Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-058-2 | CAS number: 24170-60-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A GLP-compliant test was performed to evaluate skin sensitisation of the test substance in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear according to OECD guideline 429 and EU method B.42. Following a preliminary screening test in which no clinical signs of toxicity were noted at a maximum attainable concentration of 25 % w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the test item as a suspension in acetone/olive oil 4:1 at concentrations of 25 %, 10 % or 5 % w/w. A further group of four animals was treated with acetone/olive oil 4:1 alone. Blue colored staining of the ears and fur was noted on Days 1 to 4 and prevented evaluation of erythema on both ears, on Days 1 to 3. No visual local skin irritation was noted on Days 4 to 6. No signs of systemic toxicity or irritation indicated by an equal to or greater than 25 % increase in mean ear thickness were noted. A greater than 5 % body weight loss was noted but as there was no visual evidence of systemic toxicity, local skin irritation or irritation indicated by an equal to or greater than 25 % increase in mean ear thickness the 25 % concentration was considered acceptable for use in the main test. Based on this information the dose levels selected for the main test were 25 %, 10 % and 5 % w/w in acetone/olive oil 4:1. In the main test, blue colored staining of the ears and fur was noted in all test animals, post dose on Days 1 to 3. There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. Stimulation index of 3.76, 3.21 & 3.01 was noted for concentrations 5 %, 10 % and 25 %, respectively, showing a positive result. Therefore, the test item was considered to be sensitizer under given conditions of the test.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08 September 2015 to 29 September 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch number of test material: 20140804
- Expiration date of the lot/batch: 21 August 2019
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature in the dark - Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:
Envigo RMS B.V., Inc., Horst, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation:
8 to 12 weeks
- Weight at study initiation:
15 to 23 g
- Housing:
suspended solid floor polypropylene cages furnished with softwood woodflakes
- Diet: 2014C Teklad Global Rodent diet supplied by Envigo RMS (UK) Limited, Oxon, UK)ad libitum
- Water: tap water ad libitum
- Acclimation period:
5 d
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 30 to 70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hours continuous light and 12 hours darkness.
- IN-LIFE DATES: From: 08 September 2015 to 29 September 2015 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Preliminary Screening Test: 25 % w/w
Main Test: 25 %, 10 % or 5 % w/w - No. of animals per dose:
- 4
- Details on study design:
- Test Item Formulation and Experimental Preparation:
The test item was formulated within 2 hours of being applied to the test system. It is assumed that the formulation was stable for this duration. No analysis was conducted to determine the homogeneity, concentration or stability of the test item formulation. This is an exception with regard to GLP and has been reflected in the GLP compliance statement.
Procedure
Preliminary Screening Test
Using available information regarding the irritancy potential of the test item, a preliminary screening test was performed using one mouse. The mouse was treated by daily application of 25 µL of the test item at a maximum attainable concentration of 25 % w/w in acetone/olive oil 4:1, to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Local skin irritation was scored daily. Any clinical signs of toxicity, if present, were also recorded. The body weight was recorded on Day 1 (prior to dosing) and on Day 6. The thickness of each ear was measured using a Mitutoyo 547 300S gauge (Mitutoyo Corporation), pre dose on Day 1, post dose on Day 3 and on Day 6. Any changes in the ear thickness were noted. Mean ear thickness changes were calculated between time periods Days 1 and 3 and Days 1 and 6. A mean ear thickness increase of equal to or greater than 25 % was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitization.
Main Test
Test Item Administration
Groups of four mice were treated with the test item at concentrations of 25 %, 10 % or 5 % w/w in acetone/olive oil 4:1. The preliminary screening test suggested that the test item would not produce systemic toxicity or excessive local skin irritation at the highest suitable concentration. The mice were treated by daily application of 25 µL of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner.
3H-Methyl Thymidine Administration
Five days following the first topical application of the test item or vehicle (Day 6) all mice were injected via the tail vein with 250 µL of phosphate buffered saline (PBS) containing ³H methyl thymidine (³HTdR: 80 µCi/mL, specific activity 2.0 Ci/mmoL, ARC UK Ltd) giving a total of 20 µCi to each mouse.
Observations
Clinical Observations: All animals were observed twice daily on Days 1, 2 and 3 and on a daily basis on Days 4, 5 and 6. Any signs of toxicity or signs of ill health during the test were recorded.
Body Weights: The body weight of each mouse was recorded on Day 1 (prior to dosing) and Day 6 (prior to termination).
Terminal Procedures
Termination: Five hours following the administration of 3HTdR all mice were killed by carbon dioxide asphyxiation followed by cervical separation. The draining auricular lymph nodes from the four mice were excised and pooled for each experimental group. For each group 1 mL of PBS was added to the pooled lymph nodes.
Preparation of Single Cell Suspension: A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through a 200 mesh stainless steel gauze. The lymph node cells were rinsed through the gauze with 4 mL of PBS into a petri dish labelled with the study number and dose concentration. The lymph node cell suspension was transferred to a centrifuge tube. The petri dish was washed with an additional 5 mL of PBS to remove all remaining lymph node cells and these were added to the centrifuge tube. The pooled lymph node cells were pelleted at 1400 rpm (approximately 190 g) for 10 minutes. The pellet was re suspended in 10 mL of PBS and re pelleted. To precipitate out the radioactive material, the pellet was re suspended in 3 mL of 5% Trichloroacetic acid (TCA).
Determination of ³HTdR Incorporation: After approximately 18 hours incubation at approximately 4 °C, the precipitates were recovered by centrifugation at 2100 rpm (approximately 450 g) for 10 minutes, re suspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid. ³HTdR incorporation was measured by β scintillation counting. The "Poly Q™" vials containing the samples and scintillation fluid were placed in the sample changer of the scintillator and left to stand in darkness for approximately 20 minutes. The purpose of this period of time in darkness was to reduce the risk of luminescence, which has been shown to affect the reliability of the results. After approximately 20 minutes, the vials were shaken vigorously. The number of radioactive disintegrations per minute was then measured using the Beckman LS6500 scintillation system (Beckman Instruments Inc, Fullerton, CA, USA). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- Introduction:
A study was performed to assess the sensitivity of the strain of mouse used at these laboratories to a known sensitizer. The methodology for the LLNA is detailed in the OECD Guideline for the Testing of Chemicals No. 429 and Method B.42 of Commission Regulation (EC) No. 440/2008. The study described in this document is based on these test methods but has been refined in order to reduce the number of animals required. The reduced LLNA (rLLNA) has been endorsed by the non Commission members of the European Centre for the Validation of Alternative Methods (ECVAM) Scientific Advisory Committee (ESAC) at its 26th meeting held on 26 – 27 April 2007 at ECVAM, Ispra, Italy.
Test item: α Hexylcinnamaldehyde, tech., 85%
Study number: 41500394
Study dates: 21 February 2015 to 27 February 2015
Methods
A group of five animals was treated with 50 µL (25 µL per ear) of α Hexylcinnamaldehyde, tech., 85% as a solution in acetone/olive oil 4:1 at a concentration of 25% v/v. A further control group of five animals was treated with acetone/olive oil 4:1 alone.
Results
The Stimulation Index expressed as the mean radioactive incorporation for the treatment group divided by the mean radioactive incorporation of the vehicle control group is as follows:
25 (% v/v) in acetone/olive oil 4:1 gave a Stimulation Index of 13.93 (positive).
Conclusion
α Hexylcinnamaldehyde, tech., 85% was considered to be a sensitizer under the conditions of the test. - Parameter:
- SI
- Value:
- 3.76
- Test group / Remarks:
- 5% concentration
- Parameter:
- SI
- Value:
- 3.21
- Test group / Remarks:
- 10% concentration
- Parameter:
- SI
- Value:
- 3.01
- Test group / Remarks:
- 25% concentration
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Conclusions:
- FAT 36156/D is considered as a skin sensitizer from the findings of this LLNA study.
- Executive summary:
A study was performed to assess the skin sensitization potential of FAT 36156/D in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The study was carried out according to OECD Guideline 429 and EU Method B42.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a maximum attainable concentration of 25 % w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the test item as a suspension in acetone/olive oil 4:1at concentrations of 25 %, 10 % or 5 % w/w. A further group of four animals was treated with acetone /olive oil 4:1 alone. All animals were observed twice daily on Days 1, 2 and 3 and on a daily basis on Days 4, 5 and 6 for clinical observations. Any signs of toxicity or signs of ill health during the test were recorded. The body weight of each mouse was recorded on Day 1 (prior to dosing) and Day 6 (prior to termination). Five hours following the administration of test item all mice were killed by carbon dioxide asphyxiation followed by cervical separation. The draining auricular lymph nodes from the four mice were excised and pooled for each experimental group. For each group 1 mL of PBS was added to the pooled lymph nodes. The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (disintegrations per minute/node) and as the ratio of test item incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index). Blue colored staining of the ears and fur was noted in all test animals, post dose on Days 1 to 3. There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. Body weight change of the test animals between Day 1 and Day 6 was comparable to that observed in the corresponding control group animals over the same period. The Stimulation Index for each 5, 10 and 25 % test concentration was 3.76, 3.21 and 3.01 respectively and based on these results FAT36156/D was considered to be a skin sensitizer under given conditions of the test.
Reference
Preliminary Screening Test
Blue colored staining of the ears and fur was noted on Days 1 to 4 and prevented evaluation of erythema on both ears, on Days 1 to 3. No visual local skin irritation was noted on Days 4 to 6. No signs of systemic toxicity or irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted. A greater than 5% body weight loss was noted but as there was no visual evidence of systemic toxicity, local skin irritation or irritation indicated by an equal to or greater than 25% increase in mean ear thickness the 25 % concentration was considered acceptable for use in the main test. Based on this information the dose levels selected for the main test were 25 %,10 % and 5 % w/w in acetone/olive oil 4:1.
Estimation of the Proliferative Response of Lymph Node Cells
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (%w/w) in | Stimulation Index | Result |
5 | 3.76 | Positive |
10 | 3.21 | Positive |
25 | 3.01 | Positive |
Clinical Observations and Mortality Data
Blue colored staining of the ears and fur was noted in all test animals, post dose on Days 1 to 3. There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
Body Weight
Body weight change of the test animals between Day 1 and Day 6 was comparable to that observed in the corresponding control group animals over the same period.
Clinical Observations, Body Weight and Mortality Data – Preliminary Screening Test
Concentration | Animal Number | Body Weight (g) | Day | |||||||||
1 | 2 | 3 | 4 | 5 | 6 | |||||||
Day 1 | Day 6 | Pre-Dose | Post Dose | Pre-Dose | Post Dose | Pre-Dose | Post Dose | |||||
25 | S-1 | 21.7 | 20.1 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0Fs | 0 | 0 |
0 = No signs of systemic toxicity
Fs = Blue colored staining of the ears and fur
Local Skin Irritation – Preliminary Screening Test
Concentration | Animal Number | Local Skin Irritation | |||||||||||
Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | ||||||||
left | right | left | right | left | right | left | right | left | right | left | right | ||
25 | S-1 | ?s | ?s | ?s | ?s | ?s | ?s | 0 | 0 | 0 | 0 | 0 | 0 |
?s= Blue colored staining prevented evaluation of erythema
Measurement of Ear Thickness and Mean Ear Thickness Changes – Preliminary Screening Test
Concentration | Animal Number | Ear Thickness Measurement (mm) | |||||
Day 1 | Day 3 | Day 6 | |||||
pre‑dose | post dose | ||||||
left | right | left | right | left | right | ||
25 | S-1 | 0.22 | 0.21 | 0.23 | 0.23 | 0.21 | 0.23 |
overall mean (mm) | 0.215 | 0.230 | 0.220 | ||||
overall mean ear thickness change (%) | na | 6.977 | 2.326 |
na = Not applicable
Disintegrations per Minute, Disintegrations per Minute/Node and Stimulation Index
Concentration | dpm | dpm/Nodea | Stimulation Indexb | Result |
Vehicle | 16848.59 | 2106.07 | na | na |
5 | 63354.21 | 7919.28 | 3.76 | Positive |
10 | 54058.98 | 6757.37 | 3.21 | Positive |
25 | 50747.64 | 6343.46 | 3.01 | Positive |
dpm = Disintegrations per minut
a= Disintegrations per minute/node obtained by dividing the disintegrations per minute value by 8 (total number of lymph nodes)
b= Stimulation Index of 3.0 or greater indicates a positive result
na = Not applicable
Individual Clinical Observations and Mortality Data
Concentration | Animal Number | Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | |||
Pre-Dose | Post Dose | Pre-Dose | Post Dose | Pre-Dose | Post Dose | |||||
Vehicle | 1-1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
1-2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
1-3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
1-4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
5 | 2-1 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 |
2-2 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
2-3 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
2-4 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
10 | 3-1 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 |
3-2 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
3-3 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
3-4 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
25 | 4-1 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 |
4-2 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
4-3 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 | |
4-4 | 0 | 0Fs | 0 | 0Fs | 0 | 0Fs | 0 | 0 | 0 |
0= No signs of systemic toxicity
Fs =Blue colored staining of the ears and fur
Individual Body Weights and Body Weight Change
Concentration | Animal Number | Body Weight (g) | Body Weight Change (g) | |
Day 1 | Day 6 | |||
Vehicle | 1-1 | 17.2 | 18.3 | 1.1 |
1-2 | 18.0 | 17.4 | -0.6 | |
1-3 | 19.5 | 18.9 | -0.6 | |
1-4 | 18.2 | 19.8 | 1.6 | |
5 | 2-1 | 17.6 | 19.0 | 1.4 |
2-2 | 19.3 | 20.4 | 1.1 | |
2-3 | 20.2 | 20.9 | 0.7 | |
2-4 | 20.3 | 21.7 | 1.4 | |
10 | 3-1 | 18.9 | 19.7 | 0.8 |
3-2 | 19.0 | 18.7 | -0.3 | |
3-3 | 18.6 | 19.6 | 1.0 | |
3-4 | 19.4 | 20.8 | 1.4 | |
25 | 4-1 | 19.6 | 19.7 | 0.1 |
4-2 | 19.8 | 19.9 | 0.1 | |
4-3 | 19.8 | 20.1 | 0.3 | |
4-4 | 18.7 | 18.6 | -0.1 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the findings of the skin sensitisation study, Disperse Blue 165 -1 should be classified as a Skin Sensitiser according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.